| Literature DB >> 23720354 |
Denise Williams1, Tetsuya Mori, Alfred Reiter, Wilhelm Woessman, Angelo Rosolen, Grazyna Wrobel, Jozsef Zsiros, Anne Uyttebroeck, Ildiko Marky, Marie-Cécile Le Deley, Laurence Brugières.
Abstract
In an international study of systemic childhood ALCL, 12/463 patients had CNS involvement, three of which had isolated CNS disease. Comparative analysis of CNS positive and negative patients showed no difference in ALK positivity, immunophenotype, presence of B symptoms or other sites of disease. The lymphohistiocytic variant was over represented in the CNS positive group (36% vs. 5%). With multi-agent chemotherapy, including high dose methotrexate, Ara-C and intrathecal treatment, the event free and overall survival of the CNS positive group at 5 years were 50% (95%CI, 25-75%) and 74% (45-91%), respectively with a median follow up of 4.1 years.Entities:
Keywords: CNS disease; anaplastic large cell lymphoma; childhood; lymphohistiocytic; non-Hodgkin lymphoma
Mesh:
Substances:
Year: 2013 PMID: 23720354 DOI: 10.1002/pbc.24591
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167